(Q83283434)

English

Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trials

scientific article published on 13 February 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

title

Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trials (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

author name string

H Miles Prince

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

publication date

13 February 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

volume

53

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

page(s)

1658-1659

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

Identifiers

DOI

10.3109/10428194.2012.658571

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

retrieved

20 January 2020

PubMed publication ID

22260164

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22260164

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22260164%20AND%20SRC:MED&resulttype=core&format=json

(Q83283434)

Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trials

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)